首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Alimentary Pharmacology & Therapeutics

Alimentary Pharmacology & Therapeutics杂志,由Wiley-Blackwell Publishing Ltd出版,于1987年创刊,Semimonthly,出版语言English,ISSN:0269-2813,E-ISSN:1365-2036。

投稿咨询
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology & Therapeutics
Alimentary Pharmacology & Therapeutics
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
6.8
CiteScore
14
期刊收录
SCI、SCIE

Alimentary Pharmacology & Therapeutics(中文译名:《消化道药理学与治疗学》),ISSN:0269-2813,EISSN:1365-2036,是Wiley-Blackwell Publishing Ltd出版的国际性学术期刊,创刊于1987年,以Semimonthly形式稳定发行,2026年总发文量约239篇。该刊采用非OA开放访问,学科归属为医学 - 胃肠肝病学。该刊是医学、胃肠肝病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达6.8,2025年期刊CiteScore为14,2025年期刊自引率约8.8%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Alimentary Pharmacology & Therapeutics长期聚焦医学、胃肠肝病学及相关产业的技术应用前沿,平均审稿周期一般,3-6周,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、胃肠肝病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、CHINA MAINLAND、Australia、Italy、Canada、France等为核心发文国家与地区;UNIVERSITY OF LONDONUNIVERSITY OF CALIFORNIA SYSTEM、MAYO CLINIC、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、CIBER - CENTRO DE INVESTIGACION BIOMEDICA EN RED、HARVARD UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学 PHARMACOLOGY & PHARMACY 药学
2区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
PHARMACOLOGY & PHARMACY 药学 GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区 2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
PHARMACOLOGY & PHARMACY 药学 GASTROENTEROLOGY & HEPATOLOGY 胃肠肝病学
1区 2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 21 / 153

86.6

学科:PHARMACOLOGY & PHARMACY SCIE Q1 37 / 356

89.7

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 15 / 153

90.52

学科:PHARMACOLOGY & PHARMACY SCIE Q1 18 / 356

95.08

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 18 / 148

88.2

学科:PHARMACOLOGY & PHARMACY SCIE Q1 26 / 352

92.8

学科:GASTROENTEROLOGY & HEPATOLOGY SCIE Q1 14 / 148

90.88

学科:PHARMACOLOGY & PHARMACY SCIE Q1 18 / 353

95.04


中国学者近期发文

1
Letter: Improving the Interpretability and Portability of Tumour Burden Score-Based Prediction of Extrahepatic Progression After Transarterial Chemoembolization (TACE

Author:Li, Bingfeng; Yu, Zichen

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 63, Issue 9, pp. 1323-1324. DOI: 10.1111/apt.70562

2
Letter: Association of Diabetes Mellitus With Post-TIPS Hepatic Encephalopathy in a Predominantly Viral Cirrhosis Cohor

Author:Yi, Miao; Li, Yuanyuan; Wang, Xiaoze

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. 63, Issue 7, pp. 1073-1074. DOI: 10.1111/apt.70520

3
Letter: Are All Extra-Digestive Cancer Signals in Inflammatory Bowel Disease Telling the Same Story

Author:Jiao, Liang; Cao, Yang

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70650

4
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311

Author:Ding, Rong; Bai, Jin-Feng; Jin, Zhi-Cheng; Xiao, Yu-Dong; Chen, Jian-Jian; Zhu, Xiao-Li; Xin, Yu-Jing; Chen, Jin-Zhang; Tie, Jun; Zhu, Kang-Shun; Zhang, Lan; Shi, Hai-Bin; Liu, Rui-Bao; Xu, Ai-Bing; Ji, Fanpu; Huang, Ming-Sheng; Ji, Jian-Song; Yuan, Chun-Wang; Yang, Wei-Zhu; Xu, Guo-Hui; Tu, Qiang; Jiang, Hua; Shao, Hai-Bo; Shi, Bao-Qi; Huang, Ming; Zhong, Bin-Yan; Zhu, Hai-Dong; Ren, Zheng-Gang; Teng, Gao-Jun

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70612

5
Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangiti

Author:Gao, Ao; Ye, Xueying; Shao, Wenming; Hu, Yunfeng

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70664

6
Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis? Authors' Repl

Author:Liu, Hong-Li; Liu, Xing; Hu, Yi-Fan; Chen, Miao-Yang; Li, Sha-Sha; Wang, Xi-Xuan; Bao, Yi-Jun; Zhang, Yu; Wang, Li; Li, Rui-Qi; Chen, Shu-Ling; Xiong, Qing-Fang; Zhong, Yan-Dan; Liu, Du-Xian; Zhang, Kai; Yang, Yong-Feng

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70685

7
Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' Repl

Author:Liu, Hong-Li; Liu, Xing; Hu, Yi-Fan; Chen, Miao-Yang; Li, Sha-Sha; Wang, Xi-Xuan; Bao, Yi-Jun; Zhang, Yu; Wang, Li; Li, Rui-Qi; Chen, Shu-Ling; Xiong, Qing-Fang; Zhong, Yan-Dan; Liu, Du-Xian; Zhang, Kai; Yang, Yong-Feng

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70684

8
Letter: Beyond Survival Benefit in CHANCE2311-Important Considerations in the Interpretation of TACE Combined With Immunotherapy in Advanced HC

Author:Chen, Yinghan; Lu, Caiyun; Xu, Yucheng; Zang, Zhidong

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70686

9
Letter: Early Inflammatory Benefit Is Not Yet Equivalent to Durable Surgical Advantage After Colectomy in Colonic Crohn's Diseas

Author:Li, Jiacheng

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70700

10
Letter: Beyond Feasibility: The Need for Longer Duration and Composite NIT Endpoints in Biopsy-Free MASH Trial

Author:Dai, Wenbin; Zhang, Guochun

Journal: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; Vol. , Issue , pp. -. DOI: 10.1111/apt.70701


在线咨询

Alimentary Pharmacology & Therapeutics

国际简称:ALIMENT PHARM THER参考译名:消化道药理学与治疗学

年发文量:239 CiteScore:14 是否预警:否 Gold OA文章占比:47.44% 研究类文章占比:82.43%

杂志社联系方式:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Alimentary Pharmacology & Therapeutics